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Chorionic Villus SamplingIt is a prenatal medical procedure, performed between 8 and 11 weeks of pregnancy, in which a small sample of placenta is removed. This tissue can be obtained by transabdominal or transcervical approach and can be then further analyzed for genetic analysis such as karyotyping, fluorescence in situ hybridization (FISH), or polymerase chain reaction (PCR).A number of methods have been devised to retrieve transcervical cell (TCC) samples from endocervical canal and endometrial cavity, including smears obtained with:
•	 Cotton	swabs	or	a	cytobrush,[2]
•	 Aspiration	of	cervical	mucus	with	a	catheter[2]
•	 Endometrial	biopsy	with	a	pipette
•	 Lavage	of	endocervical	canal/uterine	cavity.
Each	method	has	its	own	benefits	and	drawback.This study is done keeping in view cost-effectiveness of obtaining transcervical CVS tissue for definitive screening and then direct karyotyping at peripheral centers. Aspiration of CVS tissue is done with infant feeding tube no. 16 under ultrasound guidance. and tissue procured is compared with the one obtained with chorionic biopsy needle.
INTRODUCTIONThe developmental abnormalities are on rise, due to increased exposure to environmental toxins and intervention in the reproductive process and so the risk to any pregnant couple of having a live-born infant with a chromosomal abnormality or structural defect had been estimated to be 3–5%.[1] The current diagnostic means such as early maternal screening and ultrasound markers (alone or in combination) identify at-risk pregnancies is more accurate and faster way.Special pregnancy screening includes:
•	 RH	testing
•	 Sonography
•	 Amniocentesis	and	chorionic	villus	biopsy:	Test	for	congenital	defects by direct sample of products of conception as indicated.
•	 Alpha	fetoprotein:	To	detect	some	neural	tube	defects	and	other conditions.Although non-invasive tests show a considerable rates of false positives and false negatives, invasive ones are more definitive but carry a significant risk of fetal loss.
ABSTRACT
The developmental abnormalities are on rise, due to increased exposure to environmental toxins and intervention in reproductive 
process and so the risk to any pregnant couple of having up to 5% live-born infant with a chromosomal abnormality or structural 
defect had been estimated to be 3–5%. Thus, the need of diagnostic means to do early maternal screening at peripheral centers 
is also required to identify at-risk pregnancies in more accurate and faster way . Of all different ways available amniocentesis and 
chorionic villus biopsy are te for congenital defects are most accurate and definitive but carry significant risk of fetal loss. Chorionic 
villus sampling done under ultrasound guidance decreases this risk and increases the accuracy of procedure. This study was done 
few years back as part of thesis in Maulana Azad Medical College along with Gynaecology and Obstetrics Department of LNJP 
Hospital. In this study, transcervical sampling of chorionic tissue was done under ultrasound guidance in females undergoing 
medical termination of pregnancy in the first trimester, and tissue was procured with chorionic villus sampling (CVS) biopsy needle 
and then with infant feeding tube. Both obtained tissues were proceeded in the same way and same environment. Of 20 samples 
done, 18 samples were successfully obtained by infant feeding tube, and of this, 16 samples were adequate to be processed. While 
with biopsy needle, tissues were obtained in all but adequate tissue obtained in 18 only. Thus, sampling by infant feeding tube is 
an cost-effective method to procure chorionic villus at peripheral centers too for screening and diagnosing genetic diseases, thus 
decreasing load on referral centres.
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Although this study was done few years back as part of thesis done by author herself, this comparison is useful to obtain tissue for analysis at peripheral areas for screening with minimum facilities.[3]
ReviewDuring pregnancy, fetal cells suitable for genetic testing can be obtained from amniotic fluid by:a. Amniocentesis,b. Placental tissue by CVS sampling, orc. Fetal blood.When this screening test needs to be performed, it carries an increased risk of miscarriage between 0.5% and 1%. There is also increased risk of limb problems in the offspring due to procedure.[4]Amniocentesis is not recommended before 15 weeks and chorionic villus sampling before 10 weeks due to increased risk of miscarriage if done before this time.
Chorionic Villus SamplingIt is a prenatal medical procedure in which a small sample of placenta is removed. It is performed between 8 and 11 weeks of pregnancy and provides information about the presence of birth defects, but it has a slightly higher risk of miscarriage than amniocentesis.Although preimplantation genetic diagnosis (PGD) is an 
alternative	 to	 prenatal	 diagnosis	 (as	 an	 adjunct	 to	 assisted	reproductive technology that requires in vitro fertilization) and involves screening for chromosomal abnormalities or single gene disorders in an embryo before implantation.[5] However, this has its own risk and high costs. Thus, PGD is not feasible as a universal diagnostic tool for genetic abnormalities in the general population. As the new approaches for prenatal diagnosis using maternal plasma are challenging for practical application, they require sophisticated and expensive technology. Transcervically obtained trophoblastic cells had many clinical applications of it like  for quantification of trophoblastc cells or genetic analysis using  flouroscence  in situ hybridization  (FISH)  or (PCR).But this procedure  of obtaining chorionic tissue has a higher  risk of miscarriage than amniocentesis.
Disadvantages of Different Methods for 
Obtaining Transcervical Chorionic Tissue
•	 Limitation	of	using	cotton	swabs	to	retrieve	TCC	samples	is	the entrapment of cells within cotton, which may reduce yield
•	 Use	 of	 cytobrush	 by	 inserting	 through	 external	 os	 to	 a	maximum depth of 2 cm and rotated a full turn during removal provides fetal cells in diagnostic quantities.
•	 Aspiration	of	endocervical	mucus	with	a	single	cannula	also	results in the detection of fetal cells in up to 70% of TCC samples from mothers, with male fetus.[2]
Another	method	is	intrauterine	lavage	(IUL)	-	where	sufficient	cell retrieval was done and correct prediction of fetal sex was done[6] - but sample size was small (n = 25).
Obtaining	TCC	samples/specimen	was	rather	easy,	but	it	contains	maternal squamous cells, blood elements, spermatozoa, and varying degrees of particulate contaminants. It is thought 
that gestational age can influence the proportion of fetal cells obtained.[6]
Hence to improve on this  fault  the  cellular  clumps were discarded 
and single cell layer of cells were obtained for immunohistochemistry 
or FISH ANALYSIS  (7). The  cellular  morphology  was also 
assessed ,as  spermatozoa and  other contaminants can  easily 
be identified.[7] The cellular morphology should also be assessed, as spermatozoa and other contaminants can easily be identified.Due to all these disadvantages, larger prospective studies are required with long-term follow-up to detect possible adverse outcomes for prenatal diagnosis by TCC sampling.Various types of useful diagnostic information can be obtained from TCC samples, and most reported studies of fetal cells obtained 
from	the	cervical	canal	or	by	IUL	are	based	on	identification	of	fetal	sex and chromosome analysis using FISH or QF-PCR. A few studies have reported the use immunohistochemistry to identify fetal cells based on their expression of specific trophoblast marker proteins.Genetic approach compared to standard karyotyping, FISH, and QF-PCR can be exquisitely sensitive for the analysis of TCC and 
IUL	samples.	PCR	amplification	in	the	presence	of	DNA	binding	dyes permits quantification of a relative number of copies.Samples can be used for immunohistochemical staining with monoclonal antibodies.The recovery and analysis of fetal cells shed from the placenta into cervical canal could provide wider availability of prenatal genetic diagnostics to the general patient population.A similar study was done by Fang et al. reported the presence of fetal cells in 60% of TCC samples retrieved by endocervical mucus aspiration using a cervical catheter made from an infant feeding tube.[6] No mucolytics was used, and sample was fixed with their samples after analyzing the cellularity.The ability to procure cytotrophoblast cells by TCC as early as 6 weeks’ gestation could make this vital information available much earlier than current technologies (analysis of fetal DNA in maternal serum).With improvements in the efficacy and safety of trophoblast collection by TCC sampling using infant feeding tube and in identification and isolation of those cells expressing trophoblast markers, small quantities of fetal DNA could be readily obtained for genetic testing. It is an easy, cost-effective way to obtain CVS sample in remote areas.These advances will provide new and safer choices for pregnant women throughout the world who are in need of prenatal diagnosis.
MATERIALS AND METHODS
The	present	study	was	conducted	jointly	in	the	Department	of	Anatomy and Gynaecology and Obstetrics, MAMC and associated 
Lok	Nayak,	G.B	Pant	and	GNEC	Hospital,	New	Delhi,	as	part	of	thesis work done there in 2001.The material for the study comprised of 20 healthy patients with 
6–12	weeks	gestation	coming	for	MTP	in	Lok	Nayak	Hospital.
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All patients were meticulously evaluated through detailed history 
sessions	and	clinical	examinations	and	then	subjected	to	routine	and special investigations for establishing the diagnosis.After obtaining written informed consent from all patients, each of 
subject	was	subjected	for	CVS,	i.e.,	ultrasound-guided	transcervical	CVS by Brahmbati’s method (sampling is done by a infant feeding tube no. 16 and CVS biopsy needle both in the same patient).
List	of	instruments	required	for	CVS:
•	 Sim’s	speculum
•	 Anterior	wall	retractor	Figure	1a	and	b
•	 CVS	sampling	cannula	no.	18G	(modified	KOH	cannula	with	slightly bulbous tip and stylet)
•	 Infant	feeding	tube	no.	16
•	 20	 cc	 syringe	 with	 5	 ml	 RPMI	medium	 and	 heparin	
(200	IU/ml)
•	 USG	sector	scanner	(5	MHZ	Figure	2).
ProcedurePatient was advised to have partially full bladder and was made to lie down in lithotomy position on the table.
External	genitalia	was	cleaned	and	disinfected	with	Savlon	and	betadine.Cervix and vagina were visualized with a speculum and cleansed with broad-spectrum antiseptic solution. Vaginal examination was carried out to find the direction and correct size of the uterus [Figure 6,7].Sonography was done to confirm:
•	 Duration	of	pregnancy
•	 Viability	of	pregnancy
•	 Rule	out	associated	complication	such	as	adnexal	masses,	
fibroids,	multiple	pregnancy,	subchorionic	haemorrhage,	and	ectopic pregnancy.Posterior vaginal wall was retracted with Sim’s speculum, and the anterior lip of cervix was grasped with a tenaculum to be able to modify the between cervical canal and antiflexed uterus.
5	MHZ	Sector	scanner	USG	probe	was	used	for	locating	gestational	
sac	and	for	chorionic	frondosum.	Under	USG	guidance,	malleable	
stainless	steel	cannula	(18G)	(modified	KCH	cannula	with	bulbous	tip) with stylet was gently introduced through the cervix to chorion frondosum [Figures 2  and 6].While holding the catheter in place, the stylet was removed gently. A 20 cc disposable syringe, containing 5 ml RPMI medium with 
heparin	(200	I.U),	was	attached	to	outer	catheter,	and	chorionic	villi was obtained by suction with gentle to and fro movements, from thickest portion of chorion frondosum.The stylet was then removed gently, and tissue was checked for the presence of adequate quantity of vascular healthy villi [Figure 8]. Contents of the syringe were then immediately transported for direct karyotyping in a simple container filled with 10 ml of nutrient medium (RPMI) after this same steps followed and infant feeding tube was introduced and sample of CVS was again collected same way by aspiration and processed for direct karyotyping [Figures 3 and 4].
OBSERVATION AND RESULT OF CVS 20 samples were obtainedof  chorionic tissue     by  aspiration through infant feeding tube first and then by chorionic biopsy needle .sampling was done  by  transcervical route under ultrasound guidance ,in  patient going for first trimester abortions.2 samples were found contaminated  out of successful obtaining of  18 cases  in which cvs tissue was obtained .Rest two were unable to obtain tissues due to  early pregnancy and not enough  suction by 20 cc syringe.CVS is estimated to be 90% accurate in blind aspirated tissue as compared to CVS biopsy needle obtained tissue in about 11% of cases and CVS cannot establish with certainity that the chromosomes in the fetus are normal. Further confirmation is 
required	 in	 such	 cases	by	amniocentesis/obtaining	 tissue	by	biopsy [Table 1]. Procurement rate of obtaining  cvs  tissue successfully by infant feeding tube is -90%  while 
Figure 1(a): Instruments used fortranscervical sampling 
Figure 1(b): Instruments used fortranscervical sampling 
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 Procurement rate of obtaining adequate tissue for processing is -80%. While success rate of obtaining tissue through biopsy needle is -100% while  Procurement rate of obtaining adequate tissue for further processing  is -85%.Adequate  material was obtained in 16 cases( by infant feeding tube ) out of 20 -patients  in 2 cases no material obtained was obtained and rest 2cases showed insufficient tissue being obtained for further analysis,(i.e  tissue obtained  in 6-7 weeks of pregnancy-- sample obtained was less than 10 mg).
Advantages of CVS
•	 Detection	of	chromosomal	abnormalities,	genetic	birth	defects,	and other genetic defects at a remote or underprivileged center.
•	 Early	detection	of	genetic	defects	in	24–48	h.
•	 Less	apprehension	of	mother.
•	 Cost-effective,	cheaper	method	if	done	by	infant	feeding	tube	for the screening of genetic abnormalities and thus decreases the load on referral centers.
Disadvantages of CVS
•	 Chance	of	having	a	miscarriage	after	CVS	is	about	1:100	(1%)
•	 Apprehension	for	procedure	in	mother,
Table 1: Duration of pregnancy versus chorionic tissue obtained
Duration of 
pregnancy
Number of 
patients
CVS biopsy obtained 
with IFT
CVS biopsy obtained with 
biopsy needle
Adequate sample 
obtained
6 weeks 1 No Obtained ‑
7 weeks 1 No Obtained Not sufficient
8 weeks 10 Yes Yes Adequate (in 8 cases only)
9 weeks 5 Yes Yes Adequate
10 weeks 2 Yes Yes Adequate
12 weeks 1 Obtained Obtained Obtained
CVS: Chorionic villus sampling, IFT-infant feeding tube
Figure 2: Ultrasound sector scan
Figure 3: Laminar flow
Figure 4: Polyver microscope
Figure 5: 9 week gestation sac showing site of chorionic tissue
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•	 Contamination	of	sample	if	not	preserved	or	cleaned	properly
•	 Need	expert	hands	to	do	this
•	 Chance	of	vaginal	bleeding	after	procedure.The new approaches for prenatal diagnosis using maternal plasma are challenging for practical application because they require sophisticated and expensive technology.
DISCUSSIONThere is an obvious attraction to any technique for obtaining tissue of fetal origin for prenatal diagnosis using simple, cheap, 
and readily available equipment in which amniotic sac is not transgressed.CVS in high-risk cases by ultrasound-guided technique is a well-established and acceptable technique (done by expert hands) and gives less failure rate. This technique of obtaining tissue by infant feeding tube can be used at peripheral centers to decrease the load on referral centers and can be used for early diagnosis (as sampling can be used for direct karyotyping). Similar kind of trial was done as a blind aspiration by transcervical method of obtaining chorionic villus in 1983.[6] The study was done on 137 patients, of which tissue was obtained in 45 patients. The collection was not successful in 8–11 weeks gestation, thus only 9% was adequate collection, and trophoblast was also contaminated by maternal tissue or blood.Alfirevic et al. conducted another study a systemic analysis of 45 studies and reported a fetal loss rate of 1.9% for amniocentesis and 2% for chorionic villus sampling.[8]The spontaneous fetal loss rate after first trimester combined test was 1.40%, whereas after CVS, it was 2.76% and 2.43% for transcervical and transabdominal approach with an additional risk of fetal loss with transcervical CVS of 1.36% (1:74), which varied according to the instrument used (0.27% for forceps and 3.12% for cannula) according to a study done by Mcweeney et al. in 2012.[9,10] However, total rate of procedure-related fetal loss after transabdominal and transcervical CVS and amniocentesis appears lower than the risks on which women are currently counseled.[4,5,8].Although  with patient councelling beforehand  ,newer technology  and  use of ultrasound guidance during procedure  the disadvantages of this procedure are reduced to minimum with low chances of fetal loss even in high risk pregnancies (transcervical route )and this finding is supported by a recent study conducted in  2017, (11) by  Alfirevic et.al  which says second  trimester amniocentesis  may be associated with high pregnancy loss when compared with transabdominal cvs sampling.Transcervical sampling when compared showed   higher risk of pregnancy loss  but results were hetrogenous.(8,12). Thus to conclude transcervical sampling of chorionic villus with infant feedind tube   can be selected as a cost effective method   at peripheral centres  for screening and  diagnosing  genetic diseases  ,thus also  decreasing load on referral centres  and beneficial  for 
Figure 6: Ultrasound guided tissue obtained by transcervical route 
(infant feeding tube)
Figure 7: Transcervical chorionic villus sampling  by biopsy needle 
(above) and  by infant feeding tube (below)
Figure 8: Chronic villus in a Petridish
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apprehensive parents too. higher risk of pregnancy loss, but results were heterogeneous.[8,12]
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